Our Technology
Leadership Team
Investor Relations
About Us
Contact Us
Investor relations
Investor Relations.
Corporate
Investor Deck
View The Deck >
News
ImmVirX In the News
|
Company Announcements
ImmVirX enters the clinic with next generation oncolytic virus
Company Announcements
April 11, 2023
Dr Malcolm McColl
ImmVirX raising $25m led by renowned healthcare VC OneVentures
Company Announcements
June 5, 2023
ImmVirX raising $25m led by renowned healthcare VC OneVentures
Company Announcements
May 19, 2021
by
ImmVirX receives $2.81M R&D tax refund for FY22
Company Announcements
November 28, 2022
ImmVirX receives $2.81M R&D tax refund for FY22
Company Announcements
May 19, 2021
by
AFR Higher Education Award Research Commercialisation
News
AFR Higher Education Award Research Commercialisation
News
Nov 13, 2020
by
ImmVirX reports on operations for FY22
Company Announcements
September 26, 2022
ImmVirX reports on operations for FY22
Company Announcements
May 19, 2021
by
ImmVirX receives $858,183 R&D tax refund
Company Announcements
ImmVirX receives $858,183 R&D tax refund
Company Announcements
May 19, 2021
by
ImmVirX extends Research Services Agreement with University of Newcastle & HMRI through to 2024
Company Announcements
December 6, 2021
ImmVirX extends Research Services Agreement with University of Newcastle & HMRI through to 2024
Company Announcements
May 19, 2021
by
ImmVirX closes upsized $25m Series A financing
Company Announcements
November 8, 2021
ImmVirX closes upsized $25m Series A financing
Company Announcements
May 19, 2021
by
Bioshares Interview: Malcolm McColl, CEO ImmVirX
News
July 13, 2021
Bioshares Interview: Malcolm McColl, CEO ImmVirX
News
Nov 13, 2020
by
ImmVirX Announces $22 Million Series A Financing
Company Announcements
May 14, 2021
ImmVirX Announces $22 Million Series A Financing
Company Announcements
May 19, 2021
by
Viralytics band gets back together for ImmVirX cancer start-up
News
May 13, 2021
Viralytics band gets back together for ImmVirX cancer start-up
News
Nov 13, 2020
by
$500m Cancer team reassembled
News
March 9, 2021
$500m Cancer team reassembled
News
Nov 13, 2020
by
New biotech venture going viral in battle against cancer
News
January 22, 2020
New biotech venture going viral in battle against cancer
News
Nov 13, 2020
by
ImmVirX featured in a recent ABC coverage of the Australian Biotech sector
News
February 12, 2020
ImmVirX featured in a recent ABC coverage of the Australian Biotech sector
News
Nov 13, 2020
by
The Newcastle Herald features Immvirx on its work to develop cutting-edge cancer therapies
News
January 22, 2020
The Newcastle Herald features Immvirx on its work to develop cutting-edge cancer therapies
News
Nov 13, 2020
by
Company Announcements
ImmVirX raising $25m led by renowned healthcare VC OneVentures
Company Announcements
June 5, 2023
ImmVirX raising $25m led by renowned healthcare VC OneVentures
Company Announcements
May 19, 2021
by
ImmVirX enters the clinic with next generation oncolytic virus
Company Announcements
April 11, 2023
ImmVirX enters the clinic with next generation oncolytic virus
Company Announcements
May 19, 2021
by
Dr Malcolm McColl
ImmVirX receives $2.81M R&D tax refund for FY22
Company Announcements
November 28, 2022
ImmVirX receives $2.81M R&D tax refund for FY22
Company Announcements
May 19, 2021
by
ImmVirX reports on operations for FY22
Company Announcements
September 26, 2022
ImmVirX reports on operations for FY22
Company Announcements
May 19, 2021
by
ImmVirX receives $858,183 R&D tax refund
Company Announcements
ImmVirX receives $858,183 R&D tax refund
Company Announcements
May 19, 2021
by
ImmVirX extends Research Services Agreement with University of Newcastle & HMRI through to 2024
Company Announcements
December 6, 2021
ImmVirX extends Research Services Agreement with University of Newcastle & HMRI through to 2024
Company Announcements
May 19, 2021
by
ImmVirX closes upsized $25m Series A financing
Company Announcements
November 8, 2021
ImmVirX closes upsized $25m Series A financing
Company Announcements
May 19, 2021
by
Resignation of Chairman – Peter Turvey
Company Announcements
August 4, 2021
Resignation of Chairman – Peter Turvey
Company Announcements
May 19, 2021
by
ImmVirX Announces $22 Million Series A Financing
Company Announcements
May 14, 2021
ImmVirX Announces $22 Million Series A Financing
Company Announcements
May 19, 2021
by
Join Our Mailing List
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Our mission is to improve outcomes for patients with cancers in which immunotherapy treatments have limited effect
About Us
Our Technology